MENU
+Compare
ORIC
Stock ticker: NASDAQ
AS OF
Nov 28 closing price
Price
$11.88
Change
+$0.06 (+0.51%)
Capitalization
1.16B

ORIC Oric Pharmaceuticals Forecast, Technical & Fundamental Analysis

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

ORIC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ORIC with price predictions
Nov 28, 2025

ORIC in +2.24% Uptrend, advancing for three consecutive days on November 28, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ORIC advanced for three days, in of 252 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 58 cases where ORIC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

ORIC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ORIC as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

ORIC moved below its 50-day moving average on November 17, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ORIC crossed bearishly below the 50-day moving average on November 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORIC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ORIC entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.843) is normal, around the industry mean (27.168). P/E Ratio (0.000) is within average values for comparable stocks, (52.496). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.897). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (334.447).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORIC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORIC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
ORIC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ORIC is expected to report earnings to rise 12.21% to -37 cents per share on March 24

Oric Pharmaceuticals ORIC Stock Earnings Reports
Q4'25
Est.
$-0.37
Q3'25
Beat
by $0.07
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.01
The last earnings report on November 13 showed earnings per share of -33 cents, beating the estimate of -40 cents. With 603.07K shares outstanding, the current market capitalization sits at 1.16B.
A.I. Advisor
published General Information

General Information

a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
240 E. Grand Avenue
Phone
+1 650 388-5600
Employees
100
Web
https://www.oricpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LBRIX32.000.22
+0.69%
ClearBridge Dividend Strategy FI
SDVSX18.340.09
+0.49%
Sit Dividend Growth S
WTMVX12.500.06
+0.48%
Segall Bryant & Hamill Glb All Cp Retail
USRAX34.960.13
+0.37%
Horizon Multi-Factor U.S. Equity Inv
FTTNX12.820.01
+0.08%
Fidelity Advisor Asset Manager 30% M

ORIC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with KYMR. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+0.51%
KYMR - ORIC
46%
Loosely correlated
+0.03%
ERAS - ORIC
45%
Loosely correlated
+1.28%
NRIX - ORIC
45%
Loosely correlated
+2.79%
ELVN - ORIC
44%
Loosely correlated
-0.51%
NUVL - ORIC
43%
Loosely correlated
+0.27%
More